Turn Complex Data Into Confident Decisions
Partner with ConcertAI's expert team to design regulatory-grade studies, dynamic cohorts, and tailored real world evidence strategies.
Evidence You Can Trust. Expertise You Can Count On.
ConcertAI's Consulting & Analytic Services team delivers regulatory-grade real-world data and evidence through expertly designed feasibility assessments, prospective and retrospective cohorts and external comparator arms. With deep oncology domain expertise and rigorous data curation, we tailor every solution to your scientific and strategic goals. Whether supporting trial submissions or post market analysis, we turn complex data into confident decisions.
Key Benefits of ConcertAI's Consulting & Analytic Services
Regulatory-Ready
Gold standard data curation and guideline compliant data processing ensure confidence in regulatory and clinical decision making.
Flexible & Fit-for-Purpose
From large dynamic registries to ultra-niche populations, we customize the data to meet your scientific needs.
Consultative
Peer-to-peer collaboration with senior scientists, biostaticians, and RWE leaders.
.svg)
Efficient
Fast turnaround times powered by accurate, reliable data with full provenance to support confident, high-impact decisions.
Core Capabilities Driving Impact
External Comparator Arms (ECA)
Regulatory-Grade RWD for Submissions
- FDA-aligned data verification processes
- Feasibility-to-execution model in under 6 months
- Supports trial benchmarking or single-arm trial context
- Proven record supporting U.S. and international submissions
Comparative Cohorts & Dynamic Registries
Tailored Real-World Comparisons
- Longitudinal cohorts across multiple therapies or indications
- Natural history, effectiveness, and post-market monitoring
- Adaptable over time with new variables or endpoints
- Curated for rare conditions, biomarkers, and specialty agents
Feasibility Assessments
Confidence Before You Commit
- Evaluate data availability, completeness, and viability
- Go/No-Go framework supports early decision making
- Targeted human review of key variables
- Optimizes trial design and ECA readiness
Use Case Highlights
From ECAs to feasibility assessments and dynamic cohort design, ConcertAI partners with biopharma teams to deliver transparent, research-grade real-world datasets tailored to their use case.
External comparator arms
supports trial results with real-world context using rigourously verified, curated patient cohorts
Natural history studies
are built using longitudinal EMR and claims to explore progression, outcomes, and unmet needs
Rare disease cohorts
are generated through targeted custom curation when standard datasets fall short
Post-market surveillance
benefits from ongoing cohort refresh and adaptability over time
Feasibility reviews
assess availability and reliability of key variables for confident study planning
